Among the top 20 DEGs, TP53INP2 was identified as a candidate gene (Fig. 1c), as our previous study revealed that TP53INP2 plays a pivotal oncogenic role in AML [21]. The gene discussed is TP53INP2; the disease is acute myeloid leukemia.